Manufacturer record
Supplied by Kerala Medical Services Corporation Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
9 batches manufactured by Supplied by Kerala Medical Services Corporation Ltd (Kerala) were declared Not of Standard Quality between June 2024 and October 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
9 records linked to Supplied by Kerala Medical Services Corporation Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Vitamin B Complex Tablet | S0010/24- 25Mfg ? · Exp ? | The sample does not conform to IP Standards with respect to ?Descriptive part? for tabletsOther | DTL ThiruvananthapuramState lab | Oct 2024 |
| Vitamin B Complex Tablet | S0008/24- 25Mfg ? · Exp ? | The sample does not conform to IP Standards with respect to ?Descriptive part? for tabletsOther | DTL ThiruvananthapuramState lab | Oct 2024 |
| Vitamin B Complex Tablet | S0009/24- 25Mfg ? · Exp ? | The sample does not conform to IP Standards with respect to ?Descriptive part? for tabletsOther | DTL ThiruvananthapuramState lab | Oct 2024 |
| Telmisartan Tab IP 40 mg | S0007/24- 25Mfg ? · Exp ? | It fails the test ?Dissolution? as per IPDissolution | DTL ThiruvananthapuramState lab | Oct 2024 |
| Vitamin B Complex tablet N.F.I.1 | S0004/24- 25Mfg ? · Exp ? | The sample does not conform to IP standard with respect to the ?Descriptive part? for tabletsOther | DTL ThiruvananthapuramState lab | Jul 2024 |
| Vitamin B Complex tablet N.F.I.1 | S0003/24- 25Mfg ? · Exp ? | The sample does not conform to IP standard with respect to the ?Descriptive part? for tabletsOther | DTL ThiruvananthapuramState lab | Jul 2024 |
| Irinotecan Inj.IP 100 mg vial | D0368/23- 24Mfg ? · Exp ? | It fails the tests particulate matter and assay as per IPAssay | DTL ThiruvananthapuramState lab | Jul 2024 |
| Chlorpromazine Tab IP 50 mg | D 0644/24- 25Mfg ? · Exp ? | The sample does not conform to IP standards. It fails the ?Descriptive part?Other | DTL ThiruvananthapuramState lab | Jul 2024 |
| Oseltamivir Cap IP 75 mg | D 0444/24- 25Mfg ? · Exp ? | The sample does not conform to IP standard with respect to the ?Descriptive part? of hard gelatin capsulesOther | DTL ThiruvananthapuramState lab | Jun 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.